The use of lorcaserin in the management of obesity: a critical appraisal
Bo Bai, Yu WangDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People’s Republic of ChinaAbstract: Obesity is a chronic disease with a high prevalence in both developed and developing countries. Effective management of this worl...
Saved in:
Main Authors: | Bo Bai (Author), Yu Wang (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypothesis: Amelioration of obesity‐induced cognitive dysfunction via a lorcaserin-betahistine combination treatment
by: Ike C. dela Peña, et al.
Published: (2022) -
Lorcaserin improves glycemic control via a melanocortin neurocircuit
by: Luke K. Burke, et al.
Published: (2017) -
Lorcaserin and metabolic disease: weight‐loss dependent and independent effects
by: H. Bays, et al.
Published: (2018) -
Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
by: Muhan Jing, et al.
Published: (2021) -
Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
by: Giuseppe Di Giovanni, et al.
Published: (2020)